RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Bharat Immunologicals and Biologicals Corporation Stock

Bharat Immunologicals and Biologicals Corporation Liabilities 2024

Bharat Immunologicals and Biologicals Corporation Liabilities

978.65 M INR

Ticker

524663.BO

ISIN

INE994B01014

In 2024, Bharat Immunologicals and Biologicals Corporation's total liabilities amounted to 978.65 M INR, a -8.86% difference from the 1.07 B INR total liabilities in the previous year.

Bharat Immunologicals and Biologicals Corporation Aktienanalyse

What does Bharat Immunologicals and Biologicals Corporation do?

Bharat Immunologicals and Biologicals Corporation ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Liabilities Details

Assessing Bharat Immunologicals and Biologicals Corporation's Liabilities

Bharat Immunologicals and Biologicals Corporation's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Bharat Immunologicals and Biologicals Corporation's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing Bharat Immunologicals and Biologicals Corporation's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

Bharat Immunologicals and Biologicals Corporation's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in Bharat Immunologicals and Biologicals Corporation’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about Bharat Immunologicals and Biologicals Corporation stock

What is the level of liabilities of Bharat Immunologicals and Biologicals Corporation this year?

Bharat Immunologicals and Biologicals Corporation has a debt balance of 978.65 M INR this year.

What were the liabilities of Bharat Immunologicals and Biologicals Corporation compared to the previous year?

The liabilities of Bharat Immunologicals and Biologicals Corporation have increased by -8.86% dropped compared to the previous year.

What are the consequences of high debt for investors of Bharat Immunologicals and Biologicals Corporation?

High liabilities can pose a risk for investors of Bharat Immunologicals and Biologicals Corporation, as they can weaken the company's financial position and impair its ability to meet its obligations.

What consequences do low liabilities have for investors in Bharat Immunologicals and Biologicals Corporation?

Low liabilities mean that Bharat Immunologicals and Biologicals Corporation has a strong financial position and is able to meet its obligations without overburdening its finances.

How does an increase in liabilities of Bharat Immunologicals and Biologicals Corporation affect the company?

An increase in liabilities of Bharat Immunologicals and Biologicals Corporation can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.

How does a reduction in the liabilities of Bharat Immunologicals and Biologicals Corporation affect the company?

A decrease in the liabilities of Bharat Immunologicals and Biologicals Corporation can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.

What are some factors that influence the liabilities of Bharat Immunologicals and Biologicals Corporation?

Some factors that can influence the liabilities of Bharat Immunologicals and Biologicals Corporation include investments, acquisitions, operating costs, and sales development.

Why is the level of liabilities of Bharat Immunologicals and Biologicals Corporation so important for investors?

The liabilities of Bharat Immunologicals and Biologicals Corporation are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.

What strategic measures can Bharat Immunologicals and Biologicals Corporation take to modify the liabilities?

To change its liabilities, Bharat Immunologicals and Biologicals Corporation can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.

How much dividend does Bharat Immunologicals and Biologicals Corporation pay?

Over the past 12 months, Bharat Immunologicals and Biologicals Corporation paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Bharat Immunologicals and Biologicals Corporation is expected to pay a dividend of 0 INR.

What is the dividend yield of Bharat Immunologicals and Biologicals Corporation?

The current dividend yield of Bharat Immunologicals and Biologicals Corporation is .

When does Bharat Immunologicals and Biologicals Corporation pay dividends?

Bharat Immunologicals and Biologicals Corporation pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Bharat Immunologicals and Biologicals Corporation?

Bharat Immunologicals and Biologicals Corporation paid dividends every year for the past 0 years.

What is the dividend of Bharat Immunologicals and Biologicals Corporation?

For the upcoming 12 months, dividends amounting to 0 INR are expected. This corresponds to a dividend yield of 0 %.

In which sector is Bharat Immunologicals and Biologicals Corporation located?

Bharat Immunologicals and Biologicals Corporation is assigned to the 'Health' sector.

Wann musste ich die Aktien von Bharat Immunologicals and Biologicals Corporation kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Bharat Immunologicals and Biologicals Corporation from 11/18/2024 amounting to 0 INR, you needed to have the stock in your portfolio before the ex-date on 11/18/2024.

When did Bharat Immunologicals and Biologicals Corporation pay the last dividend?

The last dividend was paid out on 11/18/2024.

What was the dividend of Bharat Immunologicals and Biologicals Corporation in the year 2023?

In the year 2023, Bharat Immunologicals and Biologicals Corporation distributed 0 INR as dividends.

In which currency does Bharat Immunologicals and Biologicals Corporation pay out the dividend?

The dividends of Bharat Immunologicals and Biologicals Corporation are distributed in INR.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Bharat Immunologicals and Biologicals Corporation

Our stock analysis for Bharat Immunologicals and Biologicals Corporation Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Bharat Immunologicals and Biologicals Corporation Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.